563 related articles for article (PubMed ID: 35608633)
1. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance.
Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R
Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633
[TBL] [Abstract][Full Text] [Related]
2. Glycoconjugate vaccines against antimicrobial resistant pathogens.
Sorieul C; Dolce M; Romano MR; Codée J; Adamo R
Expert Rev Vaccines; 2023; 22(1):1055-1078. PubMed ID: 37902243
[TBL] [Abstract][Full Text] [Related]
3. The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.
Frost I; Sati H; Garcia-Vello P; Hasso-Agopsowicz M; Lienhardt C; Gigante V; Beyer P
Lancet Microbe; 2023 Feb; 4(2):e113-e125. PubMed ID: 36528040
[TBL] [Abstract][Full Text] [Related]
4. Potential targets for next generation antimicrobial glycoconjugate vaccines.
Micoli F; Costantino P; Adamo R
FEMS Microbiol Rev; 2018 May; 42(3):388-423. PubMed ID: 29547971
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach.
Seeberger PH
Chem Rev; 2021 Apr; 121(7):3598-3626. PubMed ID: 33794090
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
[TBL] [Abstract][Full Text] [Related]
7. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
Adamo R
Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
[TBL] [Abstract][Full Text] [Related]
8. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
9. Semi-Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978.
Sianturi J; Priegue P; Hu J; Yin J; Seeberger PH
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202209556. PubMed ID: 35950629
[TBL] [Abstract][Full Text] [Related]
10. Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
Zasłona ME; Downey AM; Seeberger PH; Moscovitz O
Biochem Soc Trans; 2021 Nov; 49(5):2411-2429. PubMed ID: 34495299
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*.
Zhang S; Sella M; Sianturi J; Priegue P; Shen D; Seeberger PH
Angew Chem Int Ed Engl; 2021 Jun; 60(26):14679-14692. PubMed ID: 33852172
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-Based Vaccines: An Overview.
Hütter J; Lepenies B
Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
Khatun F; Stephenson RJ; Toth I
Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
[TBL] [Abstract][Full Text] [Related]
14. Novel strategies for development of next-generation glycoconjugate vaccines.
Avci FY
Curr Top Med Chem; 2013; 13(20):2535-40. PubMed ID: 24066893
[TBL] [Abstract][Full Text] [Related]
15. Improving vaccines against
Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
[No Abstract] [Full Text] [Related]
16. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the production of recombinant glycoconjugate vaccines.
Kay E; Cuccui J; Wren BW
NPJ Vaccines; 2019; 4():16. PubMed ID: 31069118
[TBL] [Abstract][Full Text] [Related]
18. Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.
Moeller TD; Weyant KB; DeLisa MP
Adv Biochem Eng Biotechnol; 2021; 175():355-378. PubMed ID: 30143807
[TBL] [Abstract][Full Text] [Related]
19. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
Cuccui J; Wren B
J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
[TBL] [Abstract][Full Text] [Related]
20. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
Yu Z; Tang J; Khare T; Kumar V
Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
